Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 1013-1020

  Zhang, Yunyuan ^a   Chen, Xian ^a,b,c   Qiao, Min ^a,b   Zhang, Bing Qiang ^a,b   Wang, Ning ^b,d   Zhang, Zhonglin ^b,e   Liao, Zhan ^b,f   Zeng, Liyi ^b,f   Deng, Youlin ^a,b   Deng, Fang ^b,d   Zhang, Junhui ^a,b   Yin, Liangjun ^a,b   Liu, Wei ^a,b   Zhang, Qian ^a,b   Yan, Zhengjian ^a,b   Ye, Jixing ^b,g   Wang, Zhongliang ^a,b   Zhou, Lan ^a   Luu, Hue H ^b   Haydon, Rex C ^b   He, Tong Chuan ^a   Zhang, Hongyu ^a   more..

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c QINGDAO UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^f CENTRAL SOUTH UNIVERSITY   (China)

^g CHONGQING UNIVERSITY   (China)

Author keywords

BMP signaling; BMP2; Colorectal cancer; Intestinal epithelial cells; Proliferation; Tumorigenesis

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; BMP2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; HCT116 CELL LINE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPOSON; TUMOR GROWTH; TUMOR XENOGRAFT; ADMINISTRATION AND DOSAGE; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; COLORECTAL NEOPLASMS; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; HEK293 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR INVASION;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 2; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DEPENDOVIRUS; GENETIC THERAPY; GENETIC VECTORS; HCT116 CELLS; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION;

EID: 84911923093     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3308     Document Type: Article

References (53)

1. Bertrand FE, Angus CW, Partis WJ and Sigounas G: Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 11: 4344-4351, 2012.
2. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
3. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996. (Pubitemid 26358996)
4. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes. Science 339: 1546-1558, 2013.
5. Kinzler KW, Nilbert MC, Su LK, et al: Identification of FAP locus genes from chromosome 5q21. Science 253: 661-665, 1991. (Pubitemid 21917199)
6. Chan TL, Zhao W, Leung SY and Yuen ST: BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63: 4878-4881, 2003. (Pubitemid 37022620)
7. Hardwick JC, Kodach LL, Offerhaus GJ and van den Brink GR: Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer 8: 806-812, 2008.
8. Massague J: TGF-beta signal transduction. Annu Rev Biochem 67: 753-791, 1998.
9. Massague J: How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178, 2000.
10. Thiagalingam S, Lengauer C, Leach FS, et al: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13: 343-346, 1996. (Pubitemid 26230501)
11. Howe JR, Bair JL, Sayed MG, et al: Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28: 184-187, 2001. (Pubitemid 32538067)
12. Howe JR, Roth S, Ringold JC, et al: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280: 1086-1088, 1998. (Pubitemid 28234951)
13. Howe JR, Sayed MG, Ahmed AF, et al: The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 41: 484-491, 2004. (Pubitemid 38932108)
14. Sayed MG, Ahmed AF, Ringold JR, et al: Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 9: 901-906, 2002. (Pubitemid 35265642)
15. Haramis AP, Begthel H, van den Born M, et al: De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303: 1684-1686, 2004. (Pubitemid 38338329)
16. Hardwick JC, Van Den Brink GR, Bleuming SA, et al: Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126: 111-121, 2004. (Pubitemid 38040729)
17. Loh K, Chia JA, Greco S, et al: Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer 47: 449-460, 2008. (Pubitemid 351657180)
18. Beck SE, Jung BH, Fiorino A, et al: Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J Physiol Gastrointest Liver Physiol 291: G135-G145, 2006. (Pubitemid 44024671)
19. Deng H, Makizumi R, Ravikumar TS, Dong H, Yang W and Yang WL: Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp Cell Res 313: 1033-1044, 2007. (Pubitemid 46273448)
20. Motoyama K, Tanaka F, Kosaka Y, et al: Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol 15: 1530-1537, 2008.
21. Lorente-Trigos A, Varnat F, Melotti A and Ruiz i Altaba A: BMP signaling promotes the growth of primary human colon carcinomas in vivo. J Mol Cell Biol 2: 318-332, 2010.
22. Luo X, Chen J, Song WX, et al: Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 88: 1264-1277, 2008.
23. Tang N, Song WX, Luo J, et al: BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J Cell Mol Med 13: 2448-2464, 2009.
24. Gao Y, Huang E, Zhang H, et al: Crosstalk between Wnt/β-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells. PloS One 8: e82436, 2013.
25. Kong Y, Zhang H, Chen X, et al: Destabilization of heterologous proteins mediated by the GSK3β phosphorylation domain of the β-catenin protein. Cell Physiol Biochem 32: 1187-1199, 2013.
26. Zhang W, Zhang H, Wang N, et al: Modulation of β-catenin signaling by the inhibitors of MAP kinase, tyrosine kinase, and PI3-kinase pathways. Int J Med Sci 10: 1888-1898, 2013.
27. Chen X, Luther G, Zhang W, et al: The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma Cells. Cell Physiol Biochem 32: 1083-1096, 2013.
28. Cheng H, Jiang W, Phillips FM, et al: Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A: 1544-1552, 2003. (Pubitemid 36951140)
29. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514, 1998. (Pubitemid 28145972)
30. Kang Q, Song WX, Luo Q, et al: A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 18: 545-559, 2009.
31. Kang Q, Sun MH, Cheng H, et al: Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11: 1312-1320, 2004. (Pubitemid 39213996)
32. Luo J, Deng ZL, Luo X, et al: A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2: 1236-1247, 2007. (Pubitemid 46908240)
33. Luu HH, Kang Q, Park JK, et al: An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22: 319-329, 2005. (Pubitemid 41374288)
34. Luu HH, Zhou L, Haydon RC, et al: Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett 229: 135-148, 2005. (Pubitemid 41262550)
35. He BC, Gao JL, Luo X, et al: Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/β-catenin signaling. Int J Oncol 38: 437-445, 2011.
36. He BC, Gao JL, Zhang BQ, et al: Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 79: 211-219, 2011.
37. Su Y, Luo X, He BC, et al: Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis 26: 599-610, 2009.
38. Su Y, Wagner ER, Luo Q, et al: Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 30: 3907-3917, 2011.
39. Wang J, Zhang H, Zhang W, et al: Bone morphogenetic protein-9 (BMP9) effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. Stem Cells Dev: Mar 21, 2014 (Epub ahead of print).
40. Luo Q, Kang Q, Si W, et al: Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 55958-55968, 2004. (Pubitemid 40066603)
41. Luther GA, Lamplot J, Chen X, et al: IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma. Cancer Lett 336: 222-230, 2013.
42. He BC, Chen L, Zuo GW, et al: Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res 16: 2235-2245, 2010.
43. Sharff KA, Song WX, Luo X, et al: Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem 284: 649-659, 2009.
44. Chen L, Jiang W, Huang J, et al: Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res 25: 2447-2459, 2010.
45. Zhang W, Deng ZL, Chen L, et al: Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PloS One 5: e11917, 2010.
46. Luo J, Tang M, Huang J, et al: TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem 285: 29588-29598, 2010.
47. Slattery ML, Lundgreen A, Herrick JS, Wolff RK and Caan BJ: Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer 117: 4175-4183, 2011.
48. Slattery ML, Lundgreen A, Herrick JS, et al: Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer 130: 653-664, 2012.
49. Xiang L, Wang S, Jin X, Duan W, Ding X and Zheng C: Expression of BMP2, TLR3, TLR4 and COX2 in colorectal polyps, adenoma and adenocarcinoma. Mol Med Rep 6: 973-976, 2012.
50. Kodach LL, Jacobs RJ, Voorneveld PW, et al: Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell. stemness' via the bone morphogenetic protein pathway. Gut 60: 1544-1553, 2011.
51. Beck SE, Jung BH, Del Rosario E, Gomez J and Carethers JM: BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. Cell Signal 19: 1465-1472, 2007. (Pubitemid 46818912)
52. Kang MH, Kang HN, Kim JL, Kim JS, Oh SC and Yoo YA: Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol Rep 22: 525-534, 2009.
53. Wu WK, Sung JJ, Wu YC, Li ZJ, Yu L and Cho CH: Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells. Br J Pharmacol 154: 632-638, 2008. (Pubitemid 351744945)